sorrento therapeutics inc
(SRNE:Consolidated Issue listed on NASDAQ Capital Market)
Michael Scott Salka
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Science Committee, Sorrento Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Mr. Michael Scott Salka serves as Chief Executive Officer of Aspyrian, CendR, and Vesper Biologics, all biotechnology companies. Mr. Salka served as Chief Executive Officer of Ambit Biosciences Corporation from 2001 to 2010. Mr. Salka Co-Founded Sequana Therapeutics, Inc. in early 1993. He served as Chief Financial Officer of Sequana Therapeutics Inc. since September 1995 and also served as its Vice President - Operations. Mr. Salka played key roles in financing it through ...
6042 Cornerstone Ct. WestPhone: 858-210-3700
San Diego, California 92121
Board Members Memberships*
Former Chief Executive Officer and Director
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Science Committee
Carnegie Mellon University
San Diego State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|